These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27871301)

  • 1. An innovative and collaborative partnership between patients with rare disease and industry-supported registries: the Global aHUS Registry.
    Woodward L; Johnson S; Walle JV; Beck J; Gasteyger C; Licht C; Ariceta G;
    Orphanet J Rare Dis; 2016 Nov; 11(1):154. PubMed ID: 27871301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The global aHUS registry: methodology and initial patient characteristics.
    Licht C; Ardissino G; Ariceta G; Cohen D; Cole JA; Gasteyger C; Greenbaum LA; Johnson S; Ogawa M; Schaefer F; Vande Walle J; Frémeaux-Bacchi V
    BMC Nephrol; 2015 Dec; 16():207. PubMed ID: 26654630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort.
    Mallett A; Hughes P; Szer J; Tuckfield A; Van Eps C; Cambell SB; Hawley C; Burke J; Kausman J; Hewitt I; Parnham A; Ford S; Isbel N
    Intern Med J; 2015 Oct; 45(10):1054-65. PubMed ID: 26247170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.
    Fakhouri F; Hourmant M; Campistol JM; Cataland SR; Espinosa M; Gaber AO; Menne J; Minetti EE; Provôt F; Rondeau E; Ruggenenti P; Weekers LE; Ogawa M; Bedrosian CL; Legendre CM
    Am J Kidney Dis; 2016 Jul; 68(1):84-93. PubMed ID: 27012908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suspected atypical haemolytic uraemic syndrome in two post-partum patients with foetal-death in utero responding to eculizumab.
    Chua J; Paizis K; He SZ; Mount P
    Nephrology (Carlton); 2017 Feb; 22 Suppl 1():18-22. PubMed ID: 28176472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical guides for atypical hemolytic uremic syndrome in Japan.
    Kato H; Nangaku M; Hataya H; Sawai T; Ashida A; Fujimaru R; Hidaka Y; Kaname S; Maruyama S; Yasuda T; Yoshida Y; Ito S; Hattori M; Miyakawa Y; Fujimura Y; Okada H; Kagami S;
    Pediatr Int; 2016 Jul; 58(7):549-55. PubMed ID: 27460397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term remission with eculizumab in atypical haemolytic uraemic syndrome.
    Carter S; Hewitt I; Kausman J
    Nephrology (Carlton); 2017 Feb; 22 Suppl 1():7-10. PubMed ID: 28176479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
    Campistol JM; Arias M; Ariceta G; Blasco M; Espinosa L; Espinosa M; Grinyó JM; Macía M; Mendizábal S; Praga M; Román E; Torra R; Valdés F; Vilalta R; Rodríguez de Córdoba S
    Nefrologia; 2015; 35(5):421-47. PubMed ID: 26456110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of eculizumab in adult patients with atypical hemolytic uremic syndrome: A single center experience from Turkey.
    Gediz F; Payzin BK; Ecemis S; Güler N; Yilmaz AF; Topcugil F; Berdeli A
    Transfus Apher Sci; 2016 Dec; 55(3):357-362. PubMed ID: 27742267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life-threatening pregnancy-associated atypical haemolytic uraemic syndrome and its response to eculizumab.
    Gately R; San A; Kurtkoti J; Parnham A
    Nephrology (Carlton); 2017 Feb; 22 Suppl 1():32-35. PubMed ID: 28176475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare partnership: patient community and industry collaboration to shape the impact of real-world evidence on the rare disease ecosystem.
    Klein TL; Bender J; Bolton S; Collin-Histed T; Daher A; De Baere L; Dong D; Hopkin J; Johnson J; Lai T; Pavlou M; Schaller T; Žnidar I
    Orphanet J Rare Dis; 2024 Jul; 19(1):262. PubMed ID: 38987844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment.
    Walle JV; Delmas Y; Ardissino G; Wang J; Kincaid JF; Haller H
    J Nephrol; 2017 Feb; 30(1):127-134. PubMed ID: 26995002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible severe kidney injury and anuria in a 3-month-old girl with atypical haemolytic uraemic syndrome under administration of eculizumab.
    Okuda Y; Ishikura K; Terano C; Harada R; Hamada R; Hataya H; Ogata K; Honda M
    Nephrology (Carlton); 2016 Mar; 21(3):261-5. PubMed ID: 26818219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical hemolytic uremic syndrome recurrence after kidney transplantation.
    Matar D; Naqvi F; Racusen LC; Carter-Monroe N; Montgomery RA; Alachkar N
    Transplantation; 2014 Dec; 98(11):1205-12. PubMed ID: 24933457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Success of eculizumab in the treatment of atypical hemolytic uremic syndrome.
    Baskin E; Gulleroglu K; Kantar A; Bayrakci U; Ozkaya O
    Pediatr Nephrol; 2015 May; 30(5):783-9. PubMed ID: 25384530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
    Parker S
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living kidney transplantation in adult patients with atypical haemolytic uraemic syndrome.
    Verhave JC; Westra D; van Hamersvelt HW; van Helden M; van de Kar NC; Wetzels JF
    Neth J Med; 2013 Sep; 71(7):342-7. PubMed ID: 24038559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.
    Fakhouri F; Delmas Y; Provot F; Barbet C; Karras A; Makdassi R; Courivaud C; Rifard K; Servais A; Allard C; Besson V; Cousin M; Châtelet V; Goujon JM; Coindre JP; Laurent G; Loirat C; Frémeaux-Bacchi V
    Am J Kidney Dis; 2014 Jan; 63(1):40-8. PubMed ID: 24021908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atypical hemolytic uremic syndrome].
    Blasco Pelicano M; Rodríguez de Córdoba S; Campistol Plana JM
    Med Clin (Barc); 2015 Nov; 145(10):438-45. PubMed ID: 25433773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.